Werner Heinz

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Andrew J. Ullmann, José María Aguado, David W. Denning et al. · Clinical Microbiology and Infection · 2018 · 1.5K citations · Full text

Diagnostic Mycology, Diagnosis, Pathology +6

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 938 citations

Antifungal Agent, Isavuconazole Versus Voriconazole, Antifungal Agents +7

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 676 citations

Single-arm Open-label Trial, Antifungal Agent, Antifungal Agents +4

Combination Antifungal Therapy for Invasive Aspergillosis

Kieren A. Marr, Haran T. Schlamm, Raoul Herbrecht et al. · Annals of Internal Medicine · 2015 · 486 citations

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

Johan Maertens, Oscar Marchetti, Raoul Herbrecht et al. · Bone Marrow Transplantation · 2010 · 465 citations

Hematological Malignancy, Translational Medicine, Antifungal Agent +8